Toripalimab Combined With Axitinib as Neoadjuvant Therapy for Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma
Latest Information Update: 07 Jun 2022
At a glance
- Drugs Axitinib (Primary) ; Toripalimab (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
Most Recent Events
- 14 May 2020 New trial record